Abstract
A 56 year old postmenopausal patient underwent a right radical mastectomy for a stage I breast cancer. An adjuvant treatment with tamoxifen was planned, but, because of patient's choice, a regular administration of the endocrine treatment started only one year after the operation. After a very short period of drug administration, she developed a steroid responsive nephrotic syndrome. We have reviewed the international literature concerning drug-induced renal disease; this is the first case of a tamoxifen-induced nephrotic syndrome.
Original language | English |
---|---|
Pages (from-to) | 2171-2172 |
Number of pages | 2 |
Journal | Anticancer Research |
Volume | 14 |
Issue number | 5 B |
Publication status | Published - 1994 |
Keywords
- Breast cancer
- Endocrine treatment
- Nephrotic syndrome
ASJC Scopus subject areas
- Cancer Research
- Oncology